Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

What's Next For Roivant? It's Not More Publicly Traded "Vants"

Machinery cogwheels, industry concept

Related Content

Myovant CEO Says Buoyant IPO Reflects High Interest In Women's Health

Oct 28 2016

Axovant's IPO: Harbinger Of A Biotech Bubble?

Jul 24 2015

Myovant On Path To Women’s Health Leadership, CEO Says

Feb 16 2017

Full Circle: David Hung Looks Forward To Axovant's Alzheimer's Data, Reflects On Medivation

Jun 27 2017

Related Companies

Roivant Sciences Ltd.

Sio Gene Therapies, Inc.

Myovant Sciences Ltd.

Roivant Sciences Ltd.

Enzyvant Therapeutics, Inc.

Urovant Sciences, Inc.

Medivation, Inc.

Bristol Myers Squibb Company

GSK plc

Pfizer Inc.

Merck & Co., Inc.

Additional Topics

Business Strategies Companies Research & Development Leadership

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window